Reproducibility of the shuttle walk test in children with cystic fibrosis;Reproductibilité du test de marche en navette chez des enfants atteints de mucoviscidose

Revue des Maladies Respiratoires

Volumn 20, Issue 5 I, 2003, Pages 711-718

  Pouessel, G ^a   Santos, C ^a   Thumerelle, C ^a   Neve, V ^a   Sardet, A ^a   Wizla, N ^a   Michaud, L ^a   Loeuille, G A ^a   Beghin, L ^b   Gottrand, F ^a   Matran, R ^a   Turck, D ^a   Deschildre, A ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b University of Lille   (France)

Author keywords

Child; Cystic Fibrosis; Exercise Test; Shuttle Walk Test

Indexed keywords

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CYSTIC FIBROSIS; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; REPRODUCIBILITY; SCHOOL CHILD; STATISTICAL ANALYSIS; WALKING;

EID: 0242539693     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Webb AK, Dodd ME, Moorcroft J: Exercise and cystic fibrosis. J R Soc Med 1995; 88 (Suppl 25): 30-6.
2. Bradley J, Howard J, Wallace E, Elborn S: Reliability, repeatability, and sensivity of the modified shuttle test in adult cystic fibrosis. Chest 2000; 117: 1666-71.
3. Singh SJ, Morgan MDL, Scott S, Walters D, Hardman AE: Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992; 47: 1019-24.
4. Ramsey BW, Boat T: Outcome measures for clinical trials in cystic fibrosis. J Pediatr 1994; 124: 177-92.
5. Karila C, de Blic J, Waernessyckle S, Benoit MR, Scheinmann P: Cardiopulmonary exercise testing in children. An individualised protocol for workload increase. Chest 2001; 120: 81-7.
6. Nichols JF, Morgan CG, Sarkin JA, Sallis JF, Kalfas KJ: Validity, reliability, and calibration of the TriTrac accelerometer as a measure of physical activity. Med Sci Sports Exerc 1999; 31: 908-12.
7. Welk GJ, Corbin CB: The validity of the TriTrac-R3D activity monitor for the assessment of physical activity in children. Res Q Exerc Sport 1995; 9: 202-9.
8. Sempé M, Pédron G, Roy-Pernot MG: Auxologie: méthodes et séquences. Paris: Théraplix; 1979.
9. Fleiss JL, Wiley J: The design and analysis of clinical experiments. ISBN 0-471-82047-4. Chapter 1. Reliability of measurement.
10. Orenstein DM: Exercise testing in cystic fibrosis. Pediatr Pulmonol 1998; 25: 223-5.
11. Solway S, Brooks D, Lacasse Y, Thomas S: A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001; 119: 256-70.
12. Balfour-Lynn IM, Prasad SA, Laverty A, Whitehead BF, Dinwiddie R: A step in the right direction: assessing exercise tolerance in cystic fibrosis. Pediatr Pulmonol 1998; 25: 278-84.
13. Guyatt GH, Thompson PJ, Berman LB, Sullivan MJ, Townsend M, Jones NL: How should we measure function in patients with chronic heart and lung disease? J Chronic Dis 1985; 38: 517-24.
14. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW: The 6-min walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985; 132: 919-23.
15. Mak VH, Bugler JR, Roberts CM, Spino SG: Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation. Thorax 1993; 48: 33-8.
16. Bernstein ML, Despars JA, Singh NP, Avalos K, Stansbury DW, Light RW: Reanalysis of the 12-min walk in patients with chronic obstructive pulmonary disease. Chest 1994; 105: 163-7.
17. Upton CJ, Tyrrell JC, Hiller EJ: Two minute walking distance in cystic fibrosis. Arch Dis Child 1988; 63: 1444-8.
18. Nixon PA, Joswiak ML, Fricker FJ: A six-minute walk test for assessing exercise tolerance in severely ill children. J Pediatr 1996; 129: 362-6.
19. Pike SE, Prasad SA, Balfour-Lynn IM: Effect of intravenous antibiotics on exercise tolerance (3-min step rest) in cystic fibrosis. Pediatr Pulmonol 2001; 32: 38-43.
20. Singh SJ, Morgan MDL, Hardman AE, Rowe C, Bardsley PA: Comparison of oxygen uptake during a conventional treadmill test and the shuttle walk test in chronic airflow limitation. Eur Respir J 1994; 7: 2016-20.
21. Revill SM, Morgan MDL, Singh SJ, Williams J, Hardman AE: The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999; 54: 213-22.
22. Bradley J, Howard J, Wallace E, Elborn S: Validity of a modified shuttle test in adult cystic fibrosis. Thorax 1999; 54: 437-9.
23. Rogers D, Smith P, John N, Oliver W, Doull IJM: Validity of a modified shuttle walk test as a measure of exercise tolerance in paediatric CF patients. J Cystic Fibrosis 2002; 1: S22.
24. Ahmaidi SB, Varray AL, Savy-Pacaux AM, Prefaut CG: Cardiorespiratory fitness evaluation by the shuttle test in asthmatic subjects during aerobic training. Chest 1993; 103: 1135-41.
25. Leger LA, Mercier D, Gadoury C, Lambert J: The multistage 20 meter shuttle run test for aerobic fitness. J Sports Sci 1988; 6: 93-101.
26. Leger LA, Lambert J, Goulet A, Rowan C, Dinelle Y: Aerobic capacity of 6 to 17 year-old Quebecois 20 meter shuttle run test with 1 minute stages. Can J Appl Sport Sci 1984; 2: 64-9.
27. 2max. Eur J Appl Physiol Occup Physiol 1982; 49: 1-12.
28. Matecki S, Paruit C, Chaussain M, Ramonatxo M, Denjean A, et le Groupe «EFR pédiatriques» de la Société de Physiologie: Indications et réalisation pratique des épreuves d'exercice chez l'enfant. Rev Mal Respir 2001; 18: 491-8.